Application of Artificial Intelligence in Precision Medicine and Healthcare
Launched by YI TING YEH · Mar 13, 2025
Trial Information
Current as of April 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of smart technology to help people with myasthenia gravis, a condition that affects muscle strength. The main goal of the study is to develop an intelligent health robot that can provide support and answer questions for patients, helping them manage their health more effectively. The trial is currently looking for participants who are at least 20 years old, have been diagnosed with myasthenia gravis, and are comfortable using a smartphone.
If you choose to participate, you will have the opportunity to use this innovative health robot and share your experiences through interviews. It’s important to note that individuals who have not been diagnosed with myasthenia gravis, those who do not use smartphones or tablets, or those who decide to leave the study early will not be eligible. This study hopes to make it easier for patients to get the help they need in a timely manner.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients diagnosed with myasthenia gravis by a physician.
- • 2. Age 20 years and above.
- • 3. Able to use a smartphone.
- Exclusion Criteria:
- • 1. Individuals not diagnosed with myasthenia gravis.
- • 2. Individuals who do not use smartphones or tablets.
- • 3. Individuals who withdraw from the group midway.
- • 4. Individuals unwilling to participate in interviews.
About Yi Ting Yeh
Yi Ting Yeh is a forward-thinking clinical trial sponsor dedicated to advancing medical research through innovative and rigorous study designs. Committed to enhancing patient outcomes, the organization specializes in conducting Phase I to Phase IV clinical trials across various therapeutic areas. With a focus on collaboration and ethical standards, Yi Ting Yeh leverages a team of experienced professionals to ensure the highest quality of data collection and analysis. By fostering partnerships with healthcare providers and research institutions, Yi Ting Yeh aims to accelerate the development of new treatments and contribute to the global advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Taipei City, Tamsui District, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported